Loss of Cholinergic Pathways in Vascular Dementia of the Binswanger Type
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
We sought to determine the changes in the cholinergic pathways, which project from the nucleus basalis of Meynert (nBM) and travel in the subinsular region, in vascular dementia of the Binswanger type (VDBT) and Alzheimer’s disease (AD). The subinsular regions were examined in 6 autopsied brains with VDBT, 5 brains with AD and 4 control brains without any neurologic diseases. The cholinergic pathway was labeled either by histochemistry for acetylcholine esterase (AChE), a degradatory enzyme of ACh, or by immunohistochemistry for choline acetyltransferase, its synthetic enzyme. The numerical density of nBM neurons did not differ significantly between these groups (163 ± 49 in the VDBT, 105 ± 82 in the AD and 198 ± 76 in the control groups), but with a tendency towards a decrease in the AD group. The subinsular cholinergic fibers were impaired, with relative preservation of the nBM neurons in VDBT, whereas both the subinsular cholinergic fibers and the nBM neurons were degraded in AD. These results indicate that the cholinergic pathway is damaged not only in AD, but also in VDBT, and may further provide a pharmacological basis for treatment with AChE inhibitors in VDBT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Erkinjuntti, T., Kurz, A., Gauthier, S., Bullock, R., Lilienfeld, S., & Damaraju, C. V. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08267-3 · Cited by 752
Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain
Selden, N. (1998) · Brain · doi:10.1093/brain/121.12.2249 · Cited by 657
MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL
O’Sullivan, M., Jarosz, J. M., Martin, R. J., Deasy, N., Powell, J. F., & Markus, H. S. (2001) · Neurology · doi:10.1212/wnl.56.5.628 · Cited by 363
Diagnostic strategies in CADASIL
Markus, H. S., Martin, R. J., Simpson, M. A., Dong, Y. B., Ali, N., Crosby, A. H., & Powell, J. F. (2002) · Neurology · doi:10.1212/wnl.59.8.1134 · Cited by 335
Auer, D. P., Pütz, B., Gössl, C., Elbel, G.-K., Gasser, T., & Dichgans, M. (2001) · Radiology · doi:10.1148/radiology.218.2.r01fe24443 · Cited by 223
Tomimoto, H., Akiguchi, I., Suenaga, T., Nishimura, M., Wakita, H., Nakamura, S., & Kimura, J. (1996) · Stroke · doi:10.1161/01.str.27.11.2069 · Cited by 204
Self-citationRivastigmine in subcortical vascular dementia
Moretti, R., Torre, P., Antonello, R. M., Cazzato, G., & Bava, A. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00280-0 · Cited by 107
Research works printed but not linked: 16
- 10.1007%2Fs004019900178 · DOI · Paper page
- 10.1126%2Fscience.7058341 · DOI · Paper page
- 10.1007%2FBF00697388 · DOI · Paper page
- 10.1007%2FBF00688058 · DOI
- 10.1111%2Fj.1600-0404.1989.tb03807.x · DOI
- 10.1136%2Fjnnp.53.11.961 · DOI · Paper page
- 10.1007%2FBF01271206 · DOI · Paper page
- 10.1159%2F000072803 · DOI · Paper page
- 10.1002%2Fana.410230617 · DOI
- 10.1053%2Fjscd.2003.5 · DOI
- 10.3171%2Fjns.2000.92.4.0676 · DOI · Paper page
- 10.1161%2Fhs1001.096622 · DOI
- 10.1093%2Fbrain%2F115.6.1827 · DOI · Paper page
- 10.1136%2Fjnnp.65.1.126 · DOI · Paper page
- 10.1097%2F00002093-200108001-00004 · DOI · Paper page
- 10.1034%2Fj.1600-0404.106.s178.1.x · DOI
Cited by
Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement
Sachdev, P., Kalaria, R., O’Brien, J., Skoog, I., Alladi, S., Black, S. E., Blacker, D., Blazer, D. G., Chen, C., Chui, H., et al. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000034 · Cited by 852
Pathology and pathogenesis of vascular cognitive impairment—a critical update
Jellinger, K. A. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00017 · Cited by 353
“, 2004), dysfunction of the cholinergic system may cause decreased CBF and hyopoperfusion as critical factors in the pathogenesis of VaD (Román et al., 2004; Tomimoto et al., 2005).”
BackgroundDichgans, M., Markus, H. S., Salloway, S., Verkkoniemi, A., Moline, M., Wang, Q., Posner, H., & Chabriat, H. S. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70046-2 · Cited by 264
Poly, C., Massaro, J. M., Seshadri, S., Wolf, P. A., Cho, E., Krall, E., Jacques, P. F., & Au, R. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.008938 · Cited by 159
“Adequate concentrations of choline in the brain are believed to protect against age-related cognitive decline and certain types of dementia, including AD (19, 20) because adequate concentrations potentially preserve neurons, brain volume, and neuronal transmissions.”
Morphologic diagnosis of “vascular dementia” — A critical update
Jellinger, K. A. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.03.006 · Cited by 150
Metadata
- Authors
- Tomimoto, H., Ohtani, R., Shibata, M., Nakamura, N., & Ihara, M.
- Venue
- Dementia and Geriatric Cognitive Disorders
- Publisher
- S. Karger AG
- Published
- 2005
- Volume
- 19
- Issue
- 5-6
- Pages
- 282-288
- ISSN
- 1420-8008 (ISSN-L)
- 1421-9824
- OpenAlex
- W2079145577
- Cited by
- 66
- References
- 8
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Loss of Cholinergic Pathways in Vascular Dementia of the Binswanger Type. https://app.cochat.ai/papers/10.1159/000084553
- The paper
- Tomimoto, H., Ohtani, R., Shibata, M., Nakamura, N., & Ihara, M. (2005). Loss of Cholinergic Pathways in Vascular Dementia of the Binswanger Type. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000084553
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.